FactSet Research Systems Azioni (NYSE: FDS)

Ultime notizie per FactSet Research Systems (NYSE:FDS) Azioni

FACTSET RESEARCH SYSTEMS INC

FactSet Research Systems

FactSet provides financial data and portfolio analytics to the Global investment community. The company aggregates data from third-party data suppliers, news sources, exchanges, brokerages, and contributors into its workstations. In addition, it provides essential portfolio analytics that companies use to monitor portfolios and address reporting requirements. Buy-side clients (including wealth and corporate clients) account for 82% of FactSet's annual subscription value. In 2015, the company acquired Portware, a provider of trade execution software. In 2017, it acquired BISAM, a risk management and performance measurement provider. In 2022, it completed its purchase of CUSIP Global Services.

XCUR

Cinque azioni da tenere d&#39;occhio oggi, inclusi Darden Restaurants e FedEx, con risultati trimestrali pronti a sorprendere.

Pre-market: 5 titoli da monitorare oggi C

FactSet Research Systems Inc. Common Stock

FactSet Research Systems Inc

Fifth District Bancorp, Inc. - Common Stock

Fifth District Bancorp Inc

WIIM

AAMI

APAM

BBDC

BCSF

Bakkt Holdings, Inc. Class A Common Stock

BKKT

BRDG

BSTZ

CCAP

CGBD

CION

CNCK

CSWC

DFIN

DIAX

DOMH

FDUS

Cohen & Steers Closed-End Opportunity Fund

GAIN

GBDC

HOOD

HTGC

MAIN

MEGL

MFIC

MORN

MSCI

NMFC

OCCI

PNNT

PSBD

PowerShares Exchange Traded Fund Trust Dynamic Mid Cap Value Portfolio

QQQX

SEIC

STEP

TCPC

VALU

VIRT

VRTS

Shares of capital market companies are trading higher following President Trump's decision to implement a 90-day pause on reciprocal tariffs for all countries except China.

FactSet Research Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDS#NYSE">FDS</a>) has outperformed the market over the past 15 years by 1.87% on an annualized basis producing an average annual return of 12.8%. Currently, FactSet Research Systems has a market capitalization of $17.38 billion. 
Buying $100 In FDS: If an investor had bought $100 of FDS stock 15 years ago, it would be worth $612.45 today based on a price of $457.01 for FDS at the time of writing.
<h3>FactSet Research Systems's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743546619_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

News

Trading Ideas

$100 Invested In This Stock 15 Years Ago Would Be Worth This Much Today

FactSet Research Systems's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDS#NYSE">FDS</a>) short percent of float has fallen 13.73% since its last report. The company recently reported that it has 1.41 million shares sold short, which is 4.21% of all regular shares that are available for trading. Based on its trading volume, it would take traders 5.21 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>FactSet Research Systems Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743527716_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for FactSet Research Systems has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing FactSet Research Systems's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, FactSet Research Systems's peer group average for short interest as a percentage of float is 3.35%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Is the Market Bullish or Bearish on FactSet Research Systems?

If you&#8217;re analyzing contrarian opportunities in 2025, this list is worth studying. It highlights names that, despite widespread skepticism, have been <a href="https://www.benzinga.com/analyst-stock-ratings">outperforming more popular picks.</a>
In a year when Wall Street&#8217;s darlings have stumbled, some of the most unloved names in the S&amp;P 500 are quietly delivering gains that put high-conviction buys to shame—and the data may challenge how investors think about analyst ratings.
In a newsletter sent Tuesday, DataTrek Research spotlighted what it called "a truly remarkable list": the 10 S&amp;P 500 companies with the highest share of &#8216;Sell&#8217; ratings from analysts. 
&#8220;History and year-to-date returns suggest it is a good place to look for longs,&#8221; analysts suggested.
<h3 class="wp-block-heading">The Contrarian Play: Most-Hated, Yet Outperforming</h3>
&#8220;Wall Street analysts don&#8217;t put &#8216;Sell&#8217; on many stocks,&#8221; Datatrek wrote.
FactSet data shows that of the 12,320 ratings issued on S&amp;P 500 stocks, 55.7% are Buys, 38.7% are Holds, and only 5.6% are Sells.
&#8220;The percentage of Buy ratings is above its 5-year (month-end) average of 55.0%. The percentage Hold ratings is below its 5-year (month-end) average of 39.1%. The percentage of Sell ratings is also below its 5-year (month-end) average of 5.9%,&#8221; FactSet said.
Here are the 10 S&amp;P 500 stocks with the highest percentage of Sell ratings:
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Company</td>
<td>Buy</td>
<td>Hold</td>
<td>Sell</td>
</tr>
<tr>
<td>Franklin Resources, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BEN#NYSE">BEN</a>)</td>
<td>0%</td>
<td>60%</td>
<td>40%</td>
</tr>
<tr>
<td>VeriSign, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRSN#NASDAQ">VRSN</a>)</td>
<td>40%</td>
<td>20%</td>
<td>40%</td>
</tr>
<tr>
<td>Expeditors Intl. of Washington, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EXPD#NYSE">EXPD</a>)</td>
<td>0%</td>
<td>61%</td>
<td>39%</td>
</tr>
<tr>
<td>T. Rowe Price Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TROW#NASDAQ">TROW</a>)</td>
<td>6%</td>
<td>59%</td>
<td>35%</td>
</tr>
<tr>
<td>Paramount Global Class B (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PARA#NASDAQ">PARA</a>)</td>
<td>13%</td>
<td>52%</td>
<td>35%</td>
</tr>
<tr>
<td>FactSet Research Systems Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDS#NYSE">FDS</a>)</td>
<td>17%</td>
<td>50%</td>
<td>33%</td>
</tr>
<tr>
<td>Lennox International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LII#NYSE">LII</a>)</td>
<td>24%</td>
<td>43%</td>
<td>33%</td>
</tr>
<tr>
<td>Garmin Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GRMN#NYSE">GRMN</a>)</td>
<td>10%</td>
<td>60%</td>
<td>30%</td>
</tr>
<tr>
<td>Consolidated Edison, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ED#NYSE">ED</a>)</td>
<td>6%</td>
<td>65%</td>
<td>29%</td>
</tr>
<tr>
<td>Southwest Airlines Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LUV#NYSE">LUV</a>)</td>
<td>20%</td>
<td>52%</td>
<td>28%</td>
</tr>
</tbody>
</table>
</figure>
As counterintuitive as it may seem, an equal-weighted portfolio of these &#8220;Sell-rated&#8221; stocks would have returned 3.89% year-to-date through March 25, 2025.
Here&#8217;s how the individual &#8220;Sell&#8221; stocks performed:
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Name</td>
<td>Total Return (YTD)</td>
</tr>
<tr>
<td>Consolidated Edison, Inc.</td>
<td>19.35%</td>
</tr>
<tr>
<td>VeriSign, Inc.</td>
<td>18.78%</td>
</tr>
<tr>
<td>Paramount Global</td>
<td>11.45%</td>
</tr>
<tr>
<td>Expeditors International of Washington, Inc.</td>
<td>6.88%</td>
</tr>
<tr>
<td>Garmin Ltd.</td>
<td>6.33%</td>
</tr>
<tr>
<td>Southwest Airlines Co.</td>
<td>3.72%</td>
</tr>
<tr>
<td>Franklin Resources, Inc.</td>
<td>-1.33%</td>
</tr>
<tr>
<td>Lennox International Inc.</td>
<td>-3.62%</td>
</tr>
<tr>
<td>FactSet Research Systems Inc.</td>
<td>-8.25%</td>
</tr>
<tr>
<td>T. Rowe Price Group, Inc.</td>
<td>-14.42%</td>
</tr>
</tbody>
<tfoot>
<tr>
<td>Average</td>
<td>3.89%</td>
</tr>
</tfoot>
</table>
</figure>
That performance handily beats the -2.36% decline of the S&amp;P 500, as tracked by the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>), and it's miles ahead of the -10% drop in the Magnificent Seven cohort, tracked by the Roundhill Magnificent Seven ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAGS#NYSE">MAGS</a>).
<h3 class="wp-block-heading">The "Buy" Darlings Didn't Deliver</h3>
Now, contrast that with the 10 most-loved stocks in the S&amp;P 500 — the ones with the highest percentage of Buy ratings.
This basket includes mega-cap giants like Amazon.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), and Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>), all ranked in the top tier for analyst sentiment.
But the returns tell a different story. An equal-weighted portfolio of these "Buy-rated" favorites would have lost 4.44% so far in 2025.
<figure class="wp-block-table is-style-stripes"> 
<table>
<thead>
<tr>
<th>Company</th>
<th>Buy</th>
<th>Hold</th>
<th>Sell</th>
<th>YTD Return</th>
</tr>
</thead>
<tbody>
<tr>
<td>UnitedHealth Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>)</td>
<td>97%</td>
<td>0%</td>
<td>3%</td>
<td>+1.97%</td>
</tr>
<tr>
<td>Delta Air Lines (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAL#NYSE">DAL</a>)</td>
<td>96%</td>
<td>0%</td>
<td>4%</td>
<td>-19.34%</td>
</tr>
<tr>
<td>VICI Properties (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VICI#NYSE">VICI</a>)</td>
<td>96%</td>
<td>4%</td>
<td>0%</td>
<td>+9.77%</td>
</tr>
<tr>
<td>Microsoft Corp. </td>
<td>95%</td>
<td>5%</td>
<td>0%</td>
<td>-6.08%</td>
</tr>
<tr>
<td>Amazon.com Inc.</td>
<td>95%</td>
<td>5%</td>
<td>0%</td>
<td>-6.22%</td>
</tr>
<tr>
<td>Nvidia Corp.</td>
<td>93%</td>
<td>7%</td>
<td>0%</td>
<td>-10.14%</td>
</tr>
<tr>
<td>United Airlines Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UAL#NASDAQ">UAL</a>)</td>
<td>92%</td>
<td>4%</td>
<td>4%</td>
<td>-18.75%</td>
</tr>
<tr>
<td>Trimble Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRMB#NASDAQ">TRMB</a>)</td>
<td>92%</td>
<td>8%</td>
<td>0%</td>
<td>-0.27%</td>
</tr>
<tr>
<td>Synopsys Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>)</td>
<td>91%</td>
<td>9%</td>
<td>0%</td>
<td>-5.79%</td>
</tr>
<tr>
<td>Teledyne Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDY#NYSE">TDY</a>)</td>
<td>91%</td>
<td>9%</td>
<td>0%</td>
<td>+10.41%</td>
</tr>
<tr>
<td>Average</td>
<td>—</td>
<td>—</td>
<td>—</td>
<td>-4.44%</td>
</tr>
</tbody>
</table>
</figure>
Bottom line, the trend offers a striking insight: being unloved by analysts doesn't necessarily doom a stock to underperformance. 
In fact, in a year marked by pullbacks in big tech and sector rotations, contrarian plays are quietly thriving.
For those willing to swim against the tide, Wall Street's least-favored stocks may hold the key to outperformance this year.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/government/regulations/25/03/44473410/trumps-tariff-rates-could-be-double-what-market-participants-expect-goldman-sachs-warns">Trump&#8217;s Tariff Rates Could Be &#8216;Double What Market Participants Expect,&#8217; Goldman Sachs Warns</a></li>
</ul>
Image created using artificial intelligence via Midjourney.

Analyst Color

Equities

Large Cap

Sector ETFs

Analyst Ratings

Tech

ETFs

AMZN

EXPD

GRMN

MAGS

MSFT

NVDA

PARA

SNPS

TRMB

TROW

VICI

VRSN

Want To Buy Stocks In 2025? There's One Conflicting Place To Find Winners, Analyst Says

BMO Capital analyst Jeffrey Silber maintains FactSet Research Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDS#NYSE">FDS</a>) with a Market Perform and lowers the price target from $498 to $466.

Price Target

BMO Capital Maintains Market Perform on FactSet Research Systems, Lowers Price Target to $466

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Baird analyst Timothy Wojs downgraded the rating for The AZEK Company Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZEK#NYSE">AZEK</a>) from Outperform to Neutral and lowered the price target from $58 to $53. AZEK shares closed at $41.39 on Friday. <a href="https://www.benzinga.com/quote/AZEK/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>BMO Capital analyst Phillip Jungwirth downgraded Civitas Resources, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIVI#NYSE">CIVI</a>) from Outperform to Market Perform and lowered the price target from $50 to $42. Civitas Resources shares closed at $34.79 on Friday. <a href="https://www.benzinga.com/quote/CIVI/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Evercore ISI Group analyst Stephen Kim downgraded the rating for Lennar Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEN#NYSE">LEN</a>) from Outperform to In-Line and lowered the price target from $159 to $131. Lennar shares closed at $115.22 on Friday. <a href="https://www.benzinga.com/quote/LEN/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>B of A Securities analyst Ronald Epstein downgraded Lockheed Martin Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>) from Buy to Neutral and cut the price target from&nbsp;$685&nbsp;to&nbsp;$485. Lockheed Martin shares closed at $439.70 on Friday. <a href="https://www.benzinga.com/quote/LMT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Redburn Atlantic analyst Colin Isaac downgraded Ecolab Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ECL#NYSE">ECL</a>) from Buy to Neutral and announced&nbsp;a $270&nbsp;price target. Ecolab shares closed at $251.00 on Thursday. &nbsp;<a href="https://www.benzinga.com/quote/ECL/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying LEN stock? Here&#8217;s what analysts think: 
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/03/44454777/top-3-risk-off-stocks-that-may-explode-this-month-2">Top 3 Risk Off Stocks That May Explode This Month</a></li>
</ul>
Photo: Shutterstock

Downgrades

Pre-Market Outlook

Markets

AZEK

CIVI

COHR

This Lennar Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Piper Sandler analyst Frank Schiraldi upgraded Valley National Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VLY#NASDAQ">VLY</a>) from Neutral to Overweight and maintained the price target of $11. Valley National shares closed at $8.85 on Friday. <a href="https://www.benzinga.com/quote/VLY/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Stifel analyst Lars Kjellberg upgraded the rating for Mativ Holdings, Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MATV#NYSE">MATV</a>) from Hold to Buy but lowered the price target from $15.5 to $10. Mativ Holdings shares closed at $6.09 on Friday. <a href="https://www.benzinga.com/quote/MATV/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Guggenheim analyst Michael Morris upgraded Pinterest, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PINS#NYSE">PINS</a>) from Neutral to Buy and raised the price target from $39 to $40. Pinterest shares closed at $32.42 on Friday. <a href="https://www.benzinga.com/quote/PINS/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Raymond James analyst Simon Leopold upgraded the rating for Coherent Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COHR#NYSE">COHR</a>) from Outperform to Strong Buy and lowered the price target from $110 to $91. Coherent shares closed at $68.24 on Friday. <a href="https://www.benzinga.com/quote/COHR/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Raymond James analyst Simon Leopold upgraded Lumentum Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LITE#NASDAQ">LITE</a>) from Outperform to Strong Buy and lowered the price target from&nbsp;$96&nbsp;to&nbsp;$82. Lumentum shares closed at $66.61 on Friday. &nbsp;<a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying PINS stock? Here&#8217;s what analysts think: 
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/03/44454777/top-3-risk-off-stocks-that-may-explode-this-month-2">Top 3 Risk Off Stocks That May Explode This Month</a></li>
</ul>
Photo: Shutterstock

Upgrades

LITE

MATV

PINS

This Pinterest Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday

UBS analyst Alex Kramm maintains FactSet Research Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDS#NYSE">FDS</a>) with a Neutral and lowers the price target from $525 to $480.

UBS Maintains Neutral on FactSet Research Systems, Lowers Price Target to $480

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Goldman Sachs analyst Matthew Sykes downgraded the rating for Charles River Laboratories International, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRL#NYSE">CRL</a>) from Buy to Neutral and lowered the price target from $190 to $170. Charles River shares closed at $165.35 on Thursday. <a href="https://www.benzinga.com/quote/CRL/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>HC Wainwright &amp; Co. analyst Matthew Caufield downgraded OptiNose, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPTN#NASDAQ">OPTN</a>) from Buy to Neutral and lowered the price target from $18 to $9. OptiNose shares closed at $9.15 on Thursday. <a href="https://www.benzinga.com/quote/OPTN/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Loop Capital analyst Rick Paterson downgraded the rating for FedEx Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDX#NYSE">FDX</a>) from Hold to Sell and lowered the price target from $283 to $221. FedEx shares closed at $246.21 on Thursday. <a href="https://www.benzinga.com/quote/FDX/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>William Blair analyst Brian Drab downgraded the rating for Valmont Industries, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VMI#NYSE">VMI</a>) from Outperform to Market Perform. Valmont Industries shares closed at $326.58 on Thursday. <a href="https://www.benzinga.com/quote/VMI/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Wells Fargo analyst Jason Haas downgraded FactSet Research Systems Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDS#NYSE">FDS</a>) from Equal-Weight to Underweight and slashed the price target from $450 to $402. FactSet Research shares closed at $430.93 on Thursday. &nbsp;<a href="https://www.benzinga.com/quote/FDS/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying FDX stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="579" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/21091713/image-198-1024x579.png" alt="" class="wp-image-835942" style="width:541px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/21091713/image-198-1024x579.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/21091713/image-198-300x170.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/21091713/image-198-768x434.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/21091713/image-198.png 1091w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/03/44414749/top-2-defensive-stocks-that-may-keep-you-up-at-night-in-march">Top 2 Defensive Stocks That May Keep You Up At Night In March</a></li>
</ul>
Photo: Shutterstock

OPTN

This FedEx Analyst Turns Bearish; Here Are Top 5 Downgrades For Friday

Wells Fargo analyst Jason Haas downgrades FactSet Research Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDS#NYSE">FDS</a>) from Equal-Weight to Underweight and lowers the price target from $450 to $402.

Wells Fargo Downgrades FactSet Research Systems to Underweight, Lowers Price Target to $402

Morgan Stanley analyst Toni Kaplan maintains FactSet Research Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDS#NYSE">FDS</a>) with a Underweight and lowers the price target from $409 to $390.

Morgan Stanley Maintains Underweight on FactSet Research Systems, Lowers Price Target to $390

U.S. stocks traded sideways on Thursday as investors digested Federal Reserve Chair Jerome Powell's remarks on inflation and tariffs following the Federal Open Market<a href="https://www.benzinga.com/economics/macro-economic-events/25/03/44405112/tariff-inflation-may-be-transitory-powell-says-stocks-rally-bitcoin-clears-85000-as-bulls-return"> Committee meeting on Wednesday.</a> 
Powell downplayed concerns that tariffs imposed by President Donald Trump could reignite inflation, calling their impact "transitory." Yet, the Fed's latest projections signaled slower economic growth, rising unemployment and hotter inflation. 
By midday in New York, major indexes were little changed, with financial stocks leading modest gains. 
Berkshire Hathaway Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) extended its rally to fresh record highs, on track for a sixth consecutive positive session. The stock's year-to-date outperformance over the S&amp;P 500 has widened to 20 percentage points.
In commodities, gold edged lower as the U.S. dollar strengthened, while Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) slid 2.8%, dipping below $85,000. Oil prices jumped 1.5% to $67 per barrel amid escalating geopolitical tensions, as Israel launched a new ground operation in Gaza, breaking a two-month ceasefire.
<h3 class="wp-block-heading">Thursday&#8217;s Performance In Major US Indices, ETFs</h3>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>1-day %chg</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>42,081.53</td>
<td>0.3%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,674.16</td>
<td>0.0%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,080.75</td>
<td>0.0%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>19,711.27</td>
<td>-0.1%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated at 12:30 p.m. ET</figcaption></figure>
According to&nbsp;<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1">Benzinga Pro</a>&nbsp;data:
<ul>
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) inched 0.1% down to $566.56.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>) rose 0.2% to $421.00.</li>
<li>The tech-heavy&nbsp;Invesco QQQ Trust Series&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>)&nbsp;slipped 0.2% to $479.28.</li>
<li>The&nbsp;iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) eased 0.2% to $206.03</li>
<li>The&nbsp;Financial&nbsp;Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLF#NYSE">XLF</a>) outperformed, up 0.6%; the&nbsp;Technology&nbsp;Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLY#NYSE">XLY</a>) lagged, down 0.6%.</li>
</ul>
<h3 class="wp-block-heading">Thursday&#8217;s Stock Movers </h3>
<ul>
<li>Darden Restaurants Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DRI#NYSE">DRI</a>) rose 5.4% in reaction to stronger-than-expected earnings. </li>
<li>Other stocks reacting to corporate earnings were Jabil Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JBL#NYSE">JBL</a>), up 5.2%, Accenture plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACN#NYSE">ACN</a>), down 7.2%, PDD Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDD#NASDAQ">PDD</a>), up 2%, Five Below Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FIVE#NYSE">FIVE</a>), up 7%, Facset Research Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDS#NYSE">FDS</a>).</li>
<li>Companies slated to report their earnings after the close include Nike Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>), Micron Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>), FedEx Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDX#NYSE">FDX</a>), Lennar Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEN#NYSE">LEN</a>). </li>
</ul>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/economics/macro-economic-events/25/03/44418891/us-home-sales-jump-in-february-median-price-nears-400000-next-big-move-could-shock-everyone-analysts-say">US Home Sales Jump In February, Median Price Nears $400,000: &#8216;Next Big Move Could Shock Everyone,&#8217; Analysts Say</a></li>
</ul>
Photo: Shutterstock

Macro Economic Events

Broad U.S. Equity ETFs

Econ #s

Economics

Federal Reserve

$BTC

SPDR Dow Jones Industrial Average ETF Trust

FIVE

Citigourp Global Markets 2% Protected Notes Linked To The Djia

Select Sector SPDR-Consumer Discretionary

Wall Street Holds Steady As Buffett's Berkshire Hathaway Notches Record Highs: What's Driving Markets Thursday?

On Thursday, FactSet Research Systems Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDS#NYSE">FDS</a>) reported second-quarter adjusted earnings per share of $4.28, <a target="_blank" href="https://www.benzinga.com/pressreleases/25/03/g44412160/factset-reports-results-for-second-quarter-2025" rel="noreferrer noopener">beating the street view of $4.16.</a>
Quarterly sales of $570.66 million (up 4.5% year over year) marginally outpaced the analyst consensus estimate of $570.61 million.
Organic&nbsp;revenues grew 4.0% year over year to $568.0 million during the second quarter.&nbsp;
Client count as of February&nbsp;28, 2025 was 8,645, a net increase of 396 clients in the past three months, mainly due to corporates, which now includes clients from the Irwin acquisition.
Annual Subscription Value was $2.306 billion at February&nbsp;28, 2025, compared with $2.185 billion a year ago. FactSet said organic ASV&nbsp;increased $19.6 million over the last three months.&nbsp;&nbsp;
Also Read: <a target="_blank" href="https://www.benzinga.com/25/03/44403148/whats-in-store-for-darden-this-earnings-season-analyst-predicts-slight-miss-in-same-store-sales" rel="noreferrer noopener">What&#8217;s In Store For Darden This Earnings Season? Analyst Predicts Slight Miss In Same-store Sales</a>
The company reported a quarterly adjusted operating margin of 37.3%, down 100 bps year over year.
A quarterly&nbsp;dividend&nbsp;of $39.5 million, or $1.04 per share, is being paid on March 20 to holders of record of business on February 28.
According to&nbsp;<a target="_blank" href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" rel="noreferrer noopener">Benzinga Pro</a>, FDS stock has lost over 10% in the past year. Investors can gain exposure to the stock via&nbsp;Gabelli ETFs Trust Gabelli Financial Services Opportunities ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GABF#NYSE">GABF</a>).
FactSet exited the quarter with cash and equivalents worth $278.54 million. The company&#8217;s long-term debt expanded to $1.472 billion at the end of the quarter from $1.241 billion as of August 31, 2024.
FY25 Outlook: FactSet reiterated its adjusted diluted EPS outlook of <a href="https://www.benzinga.com/calendars/guidance">$16.80 to $17.40 (consensus: $17.16).</a>
&#8220;With increased visibility into the remainder of the fiscal year, we are reaffirming the 5% midpoint of our organic ASV growth guidance and narrowing the range of anticipated top-line outcomes,&#8221; said Phil Snow, CEO of FactSet.
The company projects revenues in the range of $2.305 billion to $2.325 billion (consensus: $2.309 billion), up from the prior view of $2.285 billion to $2.305 billion.
FactSet projects adjusted operating margin in the range of 36% to 37%, unchanged from the prior view.
Price Action: FDS shares closed lower by 0.32% at $438.40 on Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/03/44402479/branchouts-partnership-with-microdried-expected-to-boost-annual-sales-by-at-least-5-million" target="_blank" rel="noreferrer noopener">BranchOut&#8217;s Partnership With MicroDried Expected To Boost Annual Sales By At Least $5 Million: Details</a></li>
</ul>
Image via Shutterstock.

Earnings

Guidance

Movers

General

Gabelli ETFs Trust Gabelli Financial Services Opportunities ETF

GABF

FactSet Surpasses Q2 Earnings Estimates, Raises FY25 Revenue Outlook Amid Client Growth

Fiscal 2025 Expectations (with reference to most recent previous guidance):
<ul>
<li>Organic ASV is expected to grow in the range of $100 million to $130 million during fiscal 2025 (narrowing from $90 million to $140 million).</li>
<li>GAAP revenues are expected to be in the range of $2,305 million to $2,325 million (up from $2,285 million to $2,305 million).</li>
<li>GAAP operating margin is expected to be in the range of 32.0% to 33.0% (down from 32.5% to 33.5%).</li>
<li>Adjusted operating margin is expected to be in the range of 36.0% to 37.0% (unchanged).</li>
<li>FactSet's annual effective tax rate is expected to be in the range of 17% to 18% (unchanged).</li>
<li>GAAP diluted EPS is expected to be in the range of $14.80 to $15.40 (down from $15.10 to $15.70).</li>
<li>Adjusted diluted EPS is expected to be in the range of $16.80 to $17.40 (unchanged).</li>
</ul>

FactSet 2025 Outlook: Cuts GAAP EPS Guidance To $14.80-$15.40 (Down From $15.10-$15.70) Vs. $15.63 Est.; Reaffirms Adjusted EPS Of $16.80-$17.40 Vs. $17.16 Est.

FactSet 2025 Outlook: Raised GAAP Revenues Guidance To $2.305B-$2.325M (Up From $2.285B-$2.305B) Vs. $2.309B Est.; Reiterated Adjusted Operating Margin Of 36.0%-37.0%

FactSet Research Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDS#NYSE">FDS</a>) reported quarterly earnings of $4.28 per share which beat the analyst consensus estimate of $4.16 by 2.88 percent. This is a 1.42 percent increase over earnings of $4.22 per share from the same period last year. The company reported quarterly sales of $570.66 million which beat the analyst consensus estimate of $570.61 million by 0.01 percent. This is a 4.53 percent increase over sales of $545.95 million the same period last year.

Earnings Beats

FactSet Research Systems Q2 2025 Adj EPS $4.28 Beats $4.16 Estimate, Sales $570.66M Beat $570.61M Estimate

<h3>Companies Reporting Before The Bell</h3>
• Star Equity Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STRR#NASDAQ">STRR</a>) is projected to report quarterly loss at $0.17 per share on revenue of $14.00 million. 
• Academy Sports (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASO#NASDAQ">ASO</a>) is expected to report quarterly earnings at $1.82 per share on revenue of $1.68 billion. 
• Jabil (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JBL#NYSE">JBL</a>) is estimated to report quarterly earnings at $1.83 per share on revenue of $6.40 billion. 
• Mogo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOGO#NASDAQ">MOGO</a>) is likely to report quarterly loss at $0.08 per share on revenue of $12.77 million. 
• Cognition Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGTX#NASDAQ">CGTX</a>) is expected to report earnings for its fourth quarter. 
• Alarum Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALAR#NASDAQ">ALAR</a>) is likely to report quarterly earnings at $0.02 per share on revenue of $7.48 million. 
• InflaRx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IFRX#NASDAQ">IFRX</a>) is estimated to report quarterly loss at $0.28 per share on revenue of $125 thousand. 
• Beasley Broadcast Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BBGI#NASDAQ">BBGI</a>) is likely to report earnings for its fourth quarter. 
• Adaptimmune Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADAP#NASDAQ">ADAP</a>) is estimated to report quarterly loss at $0.15 per share on revenue of $8.42 million. 
• Monte Rosa Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLUE#NASDAQ">GLUE</a>) is projected to report quarterly loss at $0.37 per share on revenue of $12.79 million. 
• Bragg Gaming Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRAG#NASDAQ">BRAG</a>) is estimated to report earnings for its fourth quarter. 
• Autolus Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUTL#NASDAQ">AUTL</a>) is likely to report quarterly loss at $0.24 per share on revenue of $2.98 million. 
• Darden Restaurants (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DRI#NYSE">DRI</a>) is estimated to report quarterly earnings at $2.79 per share on revenue of $3.22 billion. 
• FactSet Research Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDS#NYSE">FDS</a>) is likely to report quarterly earnings at $4.18 per share on revenue of $570.67 million. 
• Gambling.com Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GAMB#NASDAQ">GAMB</a>) is likely to report quarterly earnings at $0.24 per share on revenue of $35.14 million. 
• Destination XL Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXLG#NASDAQ">DXLG</a>) is likely to report quarterly earnings at $0.03 per share on revenue of $120.93 million. 
• Titan Machinery (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TITN#NASDAQ">TITN</a>) is estimated to report quarterly loss at $0.63 per share on revenue of $728.55 million. 
• Designer Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DBI#NYSE">DBI</a>) is estimated to report quarterly loss at $0.49 per share on revenue of $719.32 million. 
• Caleres (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAL#NYSE">CAL</a>) is expected to report quarterly earnings at $0.26 per share on revenue of $646.05 million. 
• NeueHealth (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEUE#NYSE">NEUE</a>) is likely to report quarterly loss at $3.99 per share on revenue of $261.80 million. 
• Commercial Metals (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMC#NYSE">CMC</a>) is estimated to report quarterly earnings at $0.30 per share on revenue of $1.75 billion. 
• Accenture (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACN#NYSE">ACN</a>) is expected to report quarterly earnings at $2.81 per share on revenue of $16.61 billion. 
• ARS Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPRY#NASDAQ">SPRY</a>) is expected to report quarterly loss at $0.12 per share on revenue of $15.90 million. 
• ZEEKR Intelligent Tech (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZK#NYSE">ZK</a>) is projected to report earnings for its fourth quarter. 
• Shoe Carnival (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCVL#NASDAQ">SCVL</a>) is estimated to report quarterly earnings at $0.44 per share on revenue of $275.92 million. 
• 111 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YI#NASDAQ">YI</a>) is expected to report earnings for its fourth quarter. 
• Rockwell Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMTI#NASDAQ">RMTI</a>) is estimated to report quarterly earnings at $0.02 per share on revenue of $22.61 million. 
• VEON (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VEON#NASDAQ">VEON</a>) is expected to report quarterly earnings at $0.77 per share on revenue of $997.00 million. 
• Valneva (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VALN#NASDAQ">VALN</a>) is estimated to report quarterly loss at $0.22 per share on revenue of $56.43 million. 
• H World Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTHT#NASDAQ">HTHT</a>) is projected to report quarterly earnings at $0.27 per share on revenue of $798.17 million. 
• 22nd Century Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XXII#NASDAQ">XXII</a>) is estimated to report earnings for its fourth quarter. 
• Twin Vee PowerCats (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VEEE#NASDAQ">VEEE</a>) is projected to report earnings for its fourth quarter. 
• PDD Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDD#NASDAQ">PDD</a>) is likely to report quarterly earnings at $2.56 per share on revenue of $15.68 billion. 
• Yiren Digital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YRD#NYSE">YRD</a>) is likely to report earnings for its fourth quarter. 
• Neuraxis (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/NRXS#AMEX">NRXS</a>) is likely to report earnings for its fourth quarter. 
• SPDR Select Sector Fund - Consumer Discretionary (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLY#NYSE">XLY</a>) is projected to report earnings for its fourth quarter. 
• Baozun (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BZUN#NASDAQ">BZUN</a>) is expected to report earnings for its fourth quarter. 
• Lands' End (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LE#NASDAQ">LE</a>) is expected to report quarterly earnings at $0.57 per share on revenue of $458.69 million. 
<h3>Companies Reporting After The Bell</h3>
• Nike (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>) is likely to report quarterly earnings at $0.29 per share on revenue of $11.01 billion. 
• FedEx (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDX#NYSE">FDX</a>) is likely to report quarterly earnings at $4.54 per share on revenue of $21.89 billion. 
• Micron Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>) is expected to report quarterly earnings at $1.42 per share on revenue of $7.89 billion. 
• United States Antimony (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/UAMY#AMEX">UAMY</a>) is estimated to report earnings for its fourth quarter. 
• SANUWAVE Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNWV#NASDAQ">SNWV</a>) is projected to report earnings for its fourth quarter. 
• Motorsport Games (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSGM#NASDAQ">MSGM</a>) is projected to report quarterly loss at $0.48 per share on revenue of $3.30 million. 
• Skye Bioscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SKYE#NASDAQ">SKYE</a>) is projected to report earnings for its fourth quarter. 
• Quantum Computing (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QUBT#NASDAQ">QUBT</a>) is expected to report quarterly loss at $0.05 per share on revenue of $200 thousand. 
• Intellicheck (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IDN#NASDAQ">IDN</a>) is likely to report quarterly loss at $0.01 per share on revenue of $5.07 million. 
• Vaxart (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VXRT#NASDAQ">VXRT</a>) is likely to report quarterly loss at $0.11 per share on revenue of $15.68 million. 
• Flux Power Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLUX#NASDAQ">FLUX</a>) is estimated to report quarterly loss at $0.09 per share on revenue of $14.50 million. 
• Cibus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CBUS#NASDAQ">CBUS</a>) is likely to report quarterly loss at $0.85 per share on revenue of $1.75 million. 
• Tenon Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNON#NASDAQ">TNON</a>) is expected to report quarterly loss at $3.77 per share on revenue of $901 thousand. 
• Amprius Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMPX#NYSE">AMPX</a>) is estimated to report quarterly loss at $0.10 per share on revenue of $7.14 million. 
• Torrid Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CURV#NYSE">CURV</a>) is projected to report quarterly loss at $0.07 per share on revenue of $263.00 million. 
• Lennar (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEN#NYSE">LEN</a>) is expected to report quarterly earnings at $1.73 per share on revenue of $7.44 billion. 
• Scholastic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCHL#NASDAQ">SCHL</a>) is projected to report quarterly loss at $0.78 per share on revenue of $347.68 million. 
• Arcadia Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RKDA#NASDAQ">RKDA</a>) is projected to report quarterly loss at $0.50 per share on revenue of $1.15 million. 
• Macrogenics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGNX#NASDAQ">MGNX</a>) is estimated to report quarterly loss at $0.66 per share on revenue of $30.93 million. 
• TELA Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TELA#NASDAQ">TELA</a>) is likely to report quarterly loss at $0.22 per share on revenue of $23.26 million. 
• Ouster (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OUST#NASDAQ">OUST</a>) is likely to report quarterly loss at $0.26 per share on revenue of $30.00 million. 
• Luminar Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LAZR#NASDAQ">LAZR</a>) is projected to report quarterly loss at $0.15 per share on revenue of $17.43 million. 
• Planet Labs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PL#NYSE">PL</a>) is expected to report quarterly loss at $0.02 per share on revenue of $62.20 million. 
• KinderCare Learning (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KLC#NYSE">KLC</a>) is estimated to report quarterly earnings at $0.05 per share on revenue of $645.37 million. 
• Runway Gwth Fin (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RWAY#NASDAQ">RWAY</a>) is likely to report quarterly earnings at $0.41 per share on revenue of $36.19 million. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ADAP

ALAR

AMPX

AUTL

BBGI

BRAG

BZUN

CBUS

CGTX

CURV

DXLG

FLUX

GAMB

GLUE

HTHT

IFRX

LAZR

MGNX

MOGO

MSGM

NEUE

NRXS

OUST

QUBT

RKDA

RMTI

RWAY

SCHL

SCVL

SKYE

SNWV

SPRY

STRR

TELA

TITN

TNON

UAMY

VALN

VEEE

VEON

VXRT

XXII

Earnings Scheduled For March 20, 2025

FactSet Research Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDS#NYSE">FDS</a>) has outperformed the market over the past 20 years by 5.78% on an annualized basis producing an average annual return of 13.96%. Currently, FactSet Research Systems has a market capitalization of $16.61 billion. 
Buying $1000 In FDS: If an investor had bought $1000 of FDS stock 20 years ago, it would be worth $13,318.60 today based on a price of $436.85 for FDS at the time of writing.
<h3>FactSet Research Systems's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741989638_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $1000 Invested In FactSet Research Systems 20 Years Ago Would Be Worth Today

FactSet Research Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDS#NYSE">FDS</a>) has been analyzed by 7 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">6</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for FactSet Research Systems, revealing an average target of $482.29, a high estimate of $518.00, and a low estimate of $409.00. This current average has increased by 0.12% from the previous average price target of $481.71. 
<img src="https://www.benzinga.com/files/images/story/2025/1741640589_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
A clear picture of FactSet Research Systems's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Ashish Sabadra</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Sector Perform</td>
<td>$503.00</td>
<td>$503.00</td>
</tr>
<tr>
<td>Jason Haas</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$450.00</td>
<td>$500.00</td>
</tr>
<tr>
<td>Jason Haas</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$500.00</td>
<td>$503.00</td>
</tr>
<tr>
<td>Jeffrey Silber</td>
<td>BMO Capital</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$518.00</td>
<td>$521.00</td>
</tr>
<tr>
<td>Shlomo Rosenbaum</td>
<td>Stifel</td>
<td>Raises</td>
<td>Hold</td>
<td>$493.00</td>
<td>$469.00</td>
</tr>
<tr>
<td>Ashish Sabadra</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Sector Perform</td>
<td>$503.00</td>
<td>$503.00</td>
</tr>
<tr>
<td>Toni Kaplan</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Underweight</td>
<td>$409.00</td>
<td>$373.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to FactSet Research Systems. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of FactSet Research Systems compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of FactSet Research Systems's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
To gain a panoramic view of FactSet Research Systems's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/FDS/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on FactSet Research Systems analyst ratings.</a>
<h2>Delving into FactSet Research Systems's Background</h2>
FactSet provides financial data and portfolio analytics to the Global investment community. The company aggregates data from third-party data suppliers, news sources, exchanges, brokerages, and contributors into its workstations. In addition, it provides essential portfolio analytics that companies use to monitor portfolios and address reporting requirements. Buy-side clients (including wealth and corporate clients) account for 82% of FactSet's annual subscription value. In 2015, the company acquired Portware, a provider of trade execution software. In 2017, it acquired BISAM, a risk management and performance measurement provider. In 2022, it completed its purchase of CUSIP Global Services.
<h3>FactSet Research Systems's Economic Impact: An Analysis</h3>
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Positive Revenue Trend: Examining FactSet Research Systems's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 4.88% as of 30 November, 2024, showcasing a substantial increase in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Financials sector.
Net Margin: FactSet Research Systems's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 26.38% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): FactSet Research Systems's ROE excels beyond industry benchmarks, reaching 7.69%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 3.7%, the company showcases effective utilization of assets.
Debt Management: FactSet Research Systems's debt-to-equity ratio is below the industry average. With a ratio of 0.78, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Demystifying FactSet Research Systems: Insights From 7 Analyst Reviews

RBC Capital analyst Ashish Sabadra reiterates FactSet Research Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDS#NYSE">FDS</a>) with a Sector Perform and maintains $503 price target.

Reiteration

RBC Capital Reiterates Sector Perform on FactSet Research Systems, Maintains $503 Price Target

Comments

FactSet Research Systems

Notizie

Ultime notizie per FactSet Research Systems (NYSE:FDS) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO